MARGONATO, ALBERTO
 Distribuzione geografica
Continente #
AS - Asia 5.188
NA - Nord America 2.911
EU - Europa 2.000
SA - Sud America 1.736
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 11.938
Nazione #
US - Stati Uniti d'America 2.786
SG - Singapore 2.272
BR - Brasile 1.455
CN - Cina 1.300
SE - Svezia 803
HK - Hong Kong 759
VN - Vietnam 456
RU - Federazione Russa 288
IT - Italia 246
DE - Germania 193
AR - Argentina 114
GB - Regno Unito 87
IE - Irlanda 79
IN - India 75
ID - Indonesia 62
FI - Finlandia 61
MX - Messico 59
AT - Austria 51
EC - Ecuador 47
CA - Canada 46
BD - Bangladesh 45
ZA - Sudafrica 41
FR - Francia 38
IQ - Iraq 36
CO - Colombia 33
NL - Olanda 32
PL - Polonia 30
ES - Italia 27
PY - Paraguay 27
TR - Turchia 25
UZ - Uzbekistan 22
JP - Giappone 21
UA - Ucraina 21
VE - Venezuela 17
PK - Pakistan 16
CL - Cile 14
PE - Perù 13
UY - Uruguay 13
IR - Iran 11
EG - Egitto 10
KR - Corea 10
MA - Marocco 10
IL - Israele 9
LT - Lituania 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
KE - Kenya 8
SA - Arabia Saudita 8
EU - Europa 7
JO - Giordania 7
AZ - Azerbaigian 6
RO - Romania 6
TN - Tunisia 6
AM - Armenia 5
OM - Oman 5
BG - Bulgaria 4
KZ - Kazakistan 4
NP - Nepal 4
AU - Australia 3
BE - Belgio 3
BO - Bolivia 3
GA - Gabon 3
GR - Grecia 3
KW - Kuwait 3
PH - Filippine 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
MY - Malesia 2
PS - Palestinian Territory 2
TW - Taiwan 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LB - Libano 1
MD - Moldavia 1
ML - Mali 1
MR - Mauritania 1
NG - Nigeria 1
Totale 11.929
Città #
Singapore 842
Dallas 777
Hong Kong 758
Shanghai 387
Ashburn 317
Hefei 317
Lawrence 299
Princeton 299
Beijing 155
Ho Chi Minh City 154
New York 129
Moscow 125
São Paulo 123
Milan 101
Hanoi 99
Dublin 79
Los Angeles 69
Rio de Janeiro 56
Nuremberg 55
Helsinki 49
Munich 43
Boardman 41
Curitiba 34
Johannesburg 27
Warsaw 26
Belo Horizonte 25
Haiphong 25
Brasília 23
Porto Alegre 23
Santa Clara 23
Brooklyn 21
Tashkent 21
Vienna 20
Campinas 19
Da Nang 19
Guarulhos 19
London 19
Stockholm 19
Tokyo 19
Chicago 18
Baghdad 17
Council Bluffs 17
Pune 17
Montreal 16
Boston 15
Chennai 15
Orem 15
Quito 15
The Dalles 15
Washington 15
Goiânia 14
Jakarta 14
Poplar 14
Guayaquil 13
Lima 13
Rome 13
Tianjin 13
Dhaka 12
Dronten 12
Guangzhou 12
Manaus 12
Santo André 12
Asunción 11
Biên Hòa 11
Buenos Aires 11
Mexico City 11
Seattle 11
Shenzhen 11
Toronto 11
Amsterdam 10
Brescia 10
Campo Grande 10
Columbus 10
Frankfurt am Main 10
Medellín 10
Montevideo 10
Recife 10
Salvador 10
Thái Bình 10
Bogotá 9
Bắc Giang 9
Canoas 9
Caxias do Sul 9
Florianópolis 9
Fortaleza 9
Houston 9
Rochester 9
São Bernardo do Campo 9
São Vicente 9
Turku 9
Ankara 8
Aracaju 8
Atlanta 8
Delhi 8
Denver 8
Hanover 8
Manchester 8
Piracicaba 8
Sorocaba 8
Amman 7
Totale 6.340
Nome #
Prognostic impact of mitral regurgitation changes after TAVI 195
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction 157
470 MYOCARDIAL FIBROSIS IN ASYMPTOMATIC PATIENTS UNDERGOING SURGERY FOR MITRAL AND AORTIC VALVE REGURGITATION 149
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 145
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 105
[New therapeutic options for the treatment of tricuspid regurgitation] 101
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 95
Heart Valve Centre Approach to Severe Tricuspid Regurgitation: Real-World Data and Outcomes 85
[Cardiovascular involvement in Erdheim-Chester syndrome: clinical and therapeutic implications]. FT Coinvolgimento cardiovascolare nella sindrome di Erdheim-Chester: aspetti clinici e terapeutici. 81
Myocardial Late Contrast Enhancement CT in Troponin-Positive Acute Chest Pain Syndrome 81
[Heart and trauma: two representative cases of chest pain after high energy impact]. FT Dolore al petto e trauma toracico: casi clinici e revisione della letteratura. 79
"Ultrasound comet-tail images": A marker of pulmonary edema - A comparative study with wedge pressure and extravascular lung water 79
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 79
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 76
Clinical implication of multimodality imaging of aortic root intramural hematoma 73
Tricuspid Regurgitation in Left Ventricular Systolic Dysfunction: Marker or Target? 73
[Changes in hemorheological parameters during physical exertion in coronary disease patients]. FT Alterazione di parametri emoreologici durante sforzo fisico in pazienti coronaropatici. 71
Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs) 69
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 67
Safety and efficacy of Direct Oral Anticoagulants (DOACs) in very elderly patients (≥ 85 years old) with non-valvular atrial fibrillation. The Experience of an Italian tertiary care center 67
Grey zones on valvular heart disease: Interventional cardiology versus cardiac surgery. Expert opinion 66
[Mitral regurgitation and hemodynamic changes in pregnancy]. FT Insufficienza mitralica e variazioni emodinamiche in gravidanza. 65
A multicenter observational study on the management of hyperglycemia in patients with acute coronary syndrome 65
Amiodarone in ventricular arrhythmias: still a valuable resource? 65
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 64
[Multi-modality imaging: mycotic abscess of a pericardial patch]. FT Imaging multimodale: ascesso micotico su patch di pericardio 63
[Intravenous nitroglycerin infusion suppresses exercise-induced arrhythmia in patients with ischemic cardiopathy: indications for chronic treatment ]. FT L'infusione endovenosa di nitroglicerina sopprime le aritmie indotte da slorzo in pazienti con cardiopatia ischemica: indicazioni per il trattamento cronico. 62
[The coronary collaterals influence in the recovery phase after exercise-induced myocardial ischemia]. FT I collaterali influenzano la fase di recupero dopo ischemia miocardica indotta da esercizio. 61
Ambulatory ECG monitoring for the detection of myocardial ischaemia. Technical implications and applications for clinical trials 61
Advances in pharmacotherapy for cardiac amyloidosis 61
Left atrial appendage closure: a new strategy for cardioembolic events despite oral anticoagulation 61
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 58
Atrial fibrillation in hypertrophic cardiomyopathy: pathophysiology, diagnosis and management 57
[Right heart failure in a patient with unexplained tricuspid regurgitation and a rare congenital heart disease]. FT Scompenso cardiaco destro in un paziente con insufficienza tricuspidale di origine incerta e una rara cardiopatia congenita. 56
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 56
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 56
Pharmacotherapy for the treatment of obstructive hypertrophic cardiomyopathy 55
Safety and efficacy of doxazosin as an "add-on" antihypertensive therapy in mild to moderate heart failure patients 53
A 'clover' coronary artery: role of coronary computed tomography to indicate optimal treatment in aneurysmal coronary artery disease 53
Effects of functional tricuspid regurgitation on renal function and long-term prognosis in patients with heart failure 53
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 53
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 53
Prognostic Value of Pre-operative Atrial Fibrillation in Patients with Secondary Mitral Regurgitation Undergoing MitraClip Implantation 52
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 51
Percutaneous Repair for Secondary Mitral Regurgitation 51
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 51
[Metabolic therapy for heart failure]. FT Terapia metabolica per l'insufficienza cardiaca 50
Valsartan for prevention of recurrent atrial fibrillation (New England Journal of Medicine (2009) 360, (1606-1617)) 50
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 50
Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillation 50
Right ventricular endomyocardial biopsy in patients with cardiac magnetic resonance showing left ventricular myocarditis 50
[Cardiac involvement by non-Hodgkin's lymphoma in an HIV-positive patient with hypertrophic obstructive cardiomyopathy]. FT Localizzazione cardiaca di linfoma non-Hodgkin in soggetto HIV positivo affetto da cardiomiopatia ipertrofica ostruttiva. 49
Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern 49
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 49
F. Caviezel, G.B. Picotti, A. Margonato, G. Slaviero, M.D. Galva, P. Camagna, G.P. Bondiolotti, M.O. Carruba, G. Pozza: Plasma adrenaline and noradrenaline concentrations in diabetic patients with and without autonomic neuropathy at rest and during sympathethic stimulation. Diabetologia. 1982 48
A high carbohydrate meal yields a lower ischemic threshold than a high fat meal in patients with stable coronary disease 48
Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation 48
A Complicated Case of Resistant Hypertension 48
Transcatheter Edge-To-Edge Repair in COAPT-ineligible Patients: Incidence and Predictors of 2-year Good Outcome 48
Comparison of enoximone echocardiography, positron emission tomography and dobutamine echocardiography for prediction of recovery of myocardial dysfunction after revascularization 48
Validation of heart and lung teleauscultation on an Internet-based system 47
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 47
Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes 46
New pharmacological targets in the treatment of heart failure: Inhibition of free fatty oxidation by trimetazidine 46
Potential Cardiologic Protective Effects of Acetylcholinesterase Inhibitors in Patients With Mild to Moderate Dementia 45
Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: Relationship to coronary anatomy and ventricular function 45
Tricuspid valve imaging 45
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 45
Functional testing as the most accurate tool for risk stratification in patients with micro-and macrovessel coronary artery disease 44
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure 44
Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man 43
Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis 43
Percutaneous left atrial appendage closure versus nonvitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk 43
Genetic and metabolic risk factors for the development of complications of type 2 diabetes mellitus 43
Meta-Analysis of Relation Between Left Ventricular Dysfunction and Outcomes After Transcatheter Mitral Edge-to-Edge Repair 42
Early detection by the Tei index of carvedilol-induced improved left ventricular function in patients with heart failure 42
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 42
Loss of Leaflet Insertion After Percutaneous Mitral Valve Repair Requiring Left Ventricular Assist Device Implantation: Usefulness of 3D Multiplanar Reconstruction 42
Genetic and metabolic risk factors for the development of late complications in type 1 (insulin dependent) diabetes 42
Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (vol 3, pg 123, 2019) 42
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 41
Intra-procedural monitoring protocol using routine transthoracic echocardiography with backup trans-oesophageal probe in transcatheter aortic valve replacement: a single centre experience 41
Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure 41
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 41
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 41
Doppler tissue imaging: A reliable method for estimation of left ventricular filling pressure in patients with mitral regurgitation 40
Risk factors for micro- and macroangiopathic complications in type 2 diabetes: lack of association with acetylator phenotype, chlorpropamide alcohol flush and ABO and Rh blood groups 40
Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation 40
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study 40
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 40
Usefulness of Transcatheter Patent Foramen Ovale Closure in Migraineurs With Moderate to Large Right-to-Left Shunt and Instrumental Evidence of Cerebrovascular Damage 39
Assessment of stress-induced pulmonary interstitial edema by chest ultrasound during exercise echocardiography and its correlation with left ventricular function 39
Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation 39
P1246Age-, body size-, and sex-specific reference values for tricuspid valve apparatus parameters by real-time three-dimensional transthoracic echocardiography 39
Safety and efficacy of first-generation and second-generation drug-eluting stents in the setting of acute coronary syndromes 38
Jugular approach for percutaneous closure of atrial septal defect 38
Beneficial Electrophysiological Effects of Trimetazidine in Patients With Postischemic Chronic Heart Failure 38
The anti-ischemic effect of trimetaxidine in patients with postprandial myocardial ischemia is unrelated to meal composition 38
Quantitative radionuclide angiocardiography using gold 195m 38
Assessment of Residual Viability by Enoximone Echocardiography in Patients with Previous Myocardial Infarction Correlation with Positron Emission Tomographic Studies and Functional Follow-Up 38
Totale 5.781
Categoria #
all - tutte 110.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202139 0 0 0 0 0 27 9 2 0 0 1 0
2021/2022181 4 1 7 79 10 15 10 7 17 4 6 21
2022/20231.611 664 327 105 17 9 180 89 104 41 34 25 16
2023/2024638 22 31 76 53 57 121 47 52 6 23 34 116
2024/20253.859 511 60 33 81 91 327 429 357 731 530 313 396
2025/20265.713 870 1.200 1.051 1.793 756 43 0 0 0 0 0 0
Totale 12.234